Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome

Pediatrics International

Volumn 52, Issue 1, 2010, Pages

  Araki, Shunsuke ^a   Ohji, Taro ^b   Shiota, Naoki ^a   Dobashi, Kazushige ^a   Shimono, Masayuki ^a   Shirahata, Akira ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b St Lucia's Hospital   (Japan)

Author keywords

Children and adolescents; Cognitive behavioral therapy; Obesity; Prader Willi Syndrome; Risperidone

Indexed keywords

FLUVOXAMINE; MAZINDOL; RISPERIDONE;

ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CHILD; CHROMOSOME DELETION; COGNITIVE THERAPY; DIET RESTRICTION; HUMAN; HYPERINSULINEMIA; HYPERURICEMIA; LIVER DISEASE; MALE; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; OBESITY; OVERNUTRITION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP APNEA SYNDROME;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD BEHAVIOR DISORDERS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIET, REDUCING; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PRADER-WILLI SYNDROME; RISPERIDONE; VIOLENCE;

EID: 76249116667     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02996.x     Document Type: Article

References (10)

1. Prader A, Labhart A, Willi H. Ein Syndrome von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach Myatonieatigem Zustand im Neugeborenenalter. Schweiz. Med. Wochenschr 1956 86: 1260 1261.
2. Holm VA, Cassidy SB, Butler MG et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993 91: 398 402.
3. Repetto GM, White LM, Bader PJ, Johnson D, Knoll JH. Interstitial duplications of chromosome region 15q11q13: Clinical and molecular characterization. Am. J. Med. Genet. 1998 79: 82 9.
4. Dykens E, Shah B. Psychiatric disorders in Prader-Willi syndrome: Epidemiology and management. CNS Drugs 2003 17: 167 178. Review.
5. Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ. Treatment with atypical antipsychotics: New indications and new populations. J. Psychiatr. Res. 2001 35: 187 191. Review.
6. McCracken JT, McGough J, Shah B et al. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 2002 347: 314 321.
7. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am. J. Psychiatry. 1986 143: 35 9.
8. Whitman BY. Understanding and managing the behavior and psychological components of Prader-Willi syndrome. In Behavior Management for persons with Prader-Willi syndrome. A collection of articles. PWSA (USA 1998 1 9.
9. Romana MS. Cognitive-behavioral therapy. Treating individuals with dual diagnoses. J. Psychosoc. Nurs. Ment. Health Serv. 2003 41: 30 5.
10. Durst R, Rubin-Jabotinsky K, Raskin S, Katz G, Zinlin J. Risperidone in treating behavioural disturbances of Prader-Willi syndrome. Acta Psychiatr. Scand. 2000 102: 461 465.